The historical rank and industry rank for China Biologic Products Holdings's Price-to-Tangible-Book or its related term are showing as below:
CBPO'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.3 Med: 2.99 Max: 4.87
Current: 3.1
During the past 13 years, China Biologic Products Holdings's highest Price to Tangible Book Ratio was 4.87. The lowest was 2.30. And the median was 2.99.
CBPO's Price-to-Tangible-Book is not ranked
in the Biotechnology industry.
Industry Median: 2.68
vs CBPO: 3.10
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
China Biologic Products Holdings Price-to-Tangible-Book Chart
Competitive Comparison of China Biologic Products Holdings's Price-to-Tangible-Book
For the Biotechnology subindustry, China Biologic Products Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Biologic Products Holdings's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, China Biologic Products Holdings's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where China Biologic Products Holdings's Price-to-Tangible-Book falls into.
China Biologic Products Holdings Price-to-Tangible-Book Calculation
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
China Biologic Products Holdings Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of China Biologic Products Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
China Biologic Products Holdings (China Biologic Products Holdings) Business Description
China Biologic Products Holdings Inc is a biopharmaceutical company principally engaged in the research, development, manufacturing and sales of human plasma-based products in China. The company operates its business through two majority owned subsidiaries, Shandong Taibang and Guizhou Taibang. China Biologic's product pipeline includes a variety of dosages across multiple product categories. Its principal products are human albumin and immunoglobulin for intravenous injection. All of the company's products are prescription medicines administered in the form of injections. China Biologic's sales model focuses on direct sales to hospitals and inoculation centers and is complemented by distributor sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CBPO has been successfully added to your 